CUV — Clinuvel Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$381.23m
- AU$131.12m
- AU$94.02m
Brief: Clinuvel Pharmaceuticals Appoints New Chair
Jefferies boosts PT on Australia's Clinuvel Pharmaceuticals
Brief: Clinuvel Pharmaceuticals Ltd Says Willem Blijdorp Will Step Down As Chairperson Of Board
Jefferies cuts Clinuvel's PT on EPP drug rollout concerns
Brief: Clinuvel Pharmaceuticals Says FY Revenue From Ordinary Activities Up 19% To A$78.3 Mln
Brief: Clinuvel Pharmaceuticals Says Scenesse Applied Under 5 Year U.S. Veterans Affairs Contract
Brief: Clinuvel Pharmaceuticals Secures IP For Melanocortins To Treat Cns Disorders
Brief: Clinuvel Pharmaceuticals Says Two Grounds Of Appeal Upheld By Nice Panel
Brief: Clinuvel Pharmaceuticals Confirms It Has No Deposits Held With Silicon Valley Bank
Australia's Clinuvel Pharmaceuticals gains on product launch
Brief: Clinuvel Pharmaceuticals Says HY Profit After Tax A$11.4 Million
Brief: Clinuvel Pharmaceuticals Posts HY Net Profit Attributable Increased 94% To A$11.4 Mln
Brief: Clinuvel Pharmaceuticals Says Qtrly Receipts From Customers A$25.5 Million
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For Commercial Distribution In Europe, USA, Among Others
Brief: Clinuvel Pharmaceuticals Submitted Formal Application To European Medicines Agency
Australia's Clinuvel Pharma set for best day in 1 year as Jefferies hikes PT
Jefferies hikes PT on Clinuvel Pharma, says business in good shape
Brief: Clinuvel Pharmaceuticals Declares Fully Franked Final Dividend Of A$0.04 Per Share
Australia Stock Exchange release from CLINUVEL PHARMAC : Change of Director's Interest Notice